Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

805
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
805

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Precipitation-Based Encapsulation of Fibrinogen in Calcium Carbonate for Non-Compressible Hemorrhage Control.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Contraction of blood clots occurs during hemostasis and hemorrhagic shock to promote closure of lacerations.

Biomaterials·2026
Same author

Local delivery of tranexamic acid for hemorrhage control in trauma: a narrative review.

Frontiers in drug delivery·2026
Same author

Dried plasma retains hemostatic function and thermal stability during Arctic military operations.

Transfusion·2025
Same author

Encapsulation of Fibrinogen With Calcium Carbonate for Hemorrhage Control.

Military medicine·2025
Same author

Emulsion-Based Encapsulation of Fibrinogen with Calcium Carbonate for Hemorrhage Control.

Journal of functional biomaterials·2025

Related Experiment Video

Updated: Jan 19, 2026

In Vitro Thrombosis Test for Ventricular Assist Devices
09:15

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

1.2K

Thromboelastographic study of biomaterials.

Henry T Peng1

  • 1Defence Research and Development Canada-Toronto, 1133 Sheppard Avenue West, Toronto, Ontario, Canada M3M 3B9.

Journal of Biomedical Materials Research. Part B, Applied Biomaterials
|June 30, 2010
PubMed
Summary
This summary is machine-generated.

Thromboelastography (TEG) assesses blood coagulation and biomaterial interactions. This review highlights TEG

More Related Videos

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
06:28

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization

Published on: June 4, 2020

7.2K
Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow
09:41

Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow

Published on: March 5, 2020

10.0K

Related Experiment Videos

Last Updated: Jan 19, 2026

In Vitro Thrombosis Test for Ventricular Assist Devices
09:15

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

1.2K
Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
06:28

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization

Published on: June 4, 2020

7.2K
Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow
09:41

Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow

Published on: March 5, 2020

10.0K

Area of Science:

  • Biomaterials Science
  • Hematology
  • Biomedical Engineering

Background:

  • Thromboelastography (TEG) is increasingly utilized for evaluating blood coagulation dynamics.
  • It offers insights into the effects of biomaterials on hemostasis, from initial clot formation to fibrinolysis.
  • TEG can elucidate the roles of fibrinogen and platelets in coagulation using various blood components.

Purpose of the Study:

  • To comprehensively review the applications of TEG in assessing blood-biomaterial interactions.
  • To explore the diverse methodologies and settings employed in TEG studies.
  • To discuss the utility of TEG for evaluating a wide array of blood-contacting materials and devices.

Main Methods:

  • Review of existing literature on TEG applications in biomaterial assessment.
  • Analysis of different TEG methodologies, including instrumentation and blood activation techniques.
  • Consideration of various study settings (in vitro, in vivo, clinical trials) and blood types (citrated, fresh).

Main Results:

  • TEG effectively evaluates both soluble and insoluble biomaterial effects on whole blood coagulation.
  • It distinguishes the contributions of fibrinogen and platelets to the coagulation cascade.
  • The review covers applications for polymers, ceramics, and various biomedical devices.

Conclusions:

  • TEG is a valuable tool for in vitro and in vivo assessment of blood-biomaterial interactions.
  • Its versatility allows for the evaluation of diverse biomaterials and medical devices.
  • Further research directions and the author's contributions to the field are outlined.